Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −3 vs. Q1 2022
- Shares held
- 8.37M
- −286.2K (−3.3%) vs. Q1 2022
- Total value
- $3.25M
- −$2.38M (−42.2%) vs. Q1 2022
- New holders
- 5
- 8 more added
- Sold out
- 8
- 12 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DSC Advisors, L.P. | 2,670,000 | $1.04M | 1.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,800,530 | $700.0K | 0.00% | +320,604+21.7% | Added |
| Renaissance Technologies LLC | 939,527 | $365.0K | 0.00% | −25,571−2.6% | Reduced |
| BlackRock Inc. | 889,609 | $346.0K | 0.00% | −112,985−11.3% | Reduced |
| Geode Capital Management, LLC | 450,203 | $175.0K | 0.00% | −20,238−4.3% | Reduced |
| State Street Corp | 210,046 | $82.0K | 0.00% | +6,200+3.0% | Added |
| Millennium Management LLC | 164,415 | $64.0K | 0.00% | −189,586−53.6% | Reduced |
| Tekla Capital Management LLC | 135,395 | $53.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 127,844 | $50.0K | 0.01% | +127,844 | New |
| Cetera Advisor Networks LLC | 115,000 | $45.0K | 0.00% | +115,000 | New |
| Franklin Resources Inc | 96,134 | $37.0K | 0.00% | −46,466−32.6% | Reduced |
| Northern Trust Corp | 89,472 | $35.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 87,428 | $34.0K | 0.00% | −2,100−2.3% | Reduced |
| Beacon Pointe Advisors, LLC | 75,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Mackenzie Financial Corp | 65,252 | $25.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 64,838 | $25.0K | 0.00% | +40,237+163.6% | Added |
| Staley Capital Advisers Inc | 62,500 | $24.0K | 0.00% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 55,064 | $21.0K | 0.00% | −10,640−16.2% | Reduced |
| Morgan Stanley | 42,109 | $16.0K | 0.00% | −2,767−6.2% | Reduced |
| Citigroup Inc | 40,000 | $16.0K | 0.00% | +38,800+3,233.3% | Added |
| Deltec Asset Management LLC | 30,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,626 | $10.0K | 0.00% | 00.0% | Unchanged |
| CSS LLC | 25,264 | $10.0K | 0.00% | 00.0% | Unchanged |
| Regentatlantic Capital LLC | 25,075 | $10.0K | 0.00% | +25,075 | New |
| Ameriprise Financial Inc | 18,479 | $7.00K | 0.00% | −2,834−13.3% | Reduced |
| LPL Financial LLC | 17,312 | $7.00K | 0.00% | −750−4.2% | Reduced |
| Tower Research Capital LLC (TRC) | 11,982 | $5.00K | 0.00% | +4,353+57.1% | Added |
| Tobias Financial Advisors, Inc. | 11,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,469 | $4.00K | 0.00% | +10,214+4,005.5% | Added |
| Russell Investments Group, Ltd. | 3,375 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,295 | $1.00K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 2,444 | $1.00K | 0.00% | +2,444 | New |
| JPMorgan Chase & Co | 171 | $0 | 0.00% | −5,091−96.8% | Reduced |
| Wells Fargo & Company | 1,511 | $0 | 0.00% | +51+3.5% | Added |
| First Manhattan Co | 2,557 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 875 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,080 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 23 | $0 | 0.00% | −344−93.7% | Reduced |
| Investors Research Corp | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 1,364 | $0 | 0.00% | +20+1.5% | Added |
| Simplex Trading, LLC | 81 | $0 | 0.00% | +81 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −236,292−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −139,381−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −98,762−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −44,591−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,364−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,104−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,229−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Dixon Hughes Goodman Wealth Advisors LLC | – | – | – | – | Not filed |